GRGDSPK, CAS 111119-28-9

Product Description: GRGDSPK (EMD 56574) is a peptide incluing Arg-Gly-Asp (RGD). GRGDSPK (EMD 56574) is an competitive and reversible inhibitory peptide for inhibiting integrin-fibronectin binding. GRGDSPK is used to study the role of integrins in bone formation and resorption[1][2].

Applications: COVID-19-immunoregulation

Formula: C28H49N11O11

References: [1]Sessions BR, et al. Effects of amino acid substitutions in and around the arginine-glycine-aspartic acid (RGD) sequence on fertilization and parthenogenetic development in mature bovine oocytes. Mol Reprod Dev. 2006 May;73(5):651-7./[2]G A Gronowicz, et al. Synthetic Peptide Containing Arg-Gly-Asp Inhibits Bone Formation and Resorption in a Mineralizing Organ Culture System of Fetal Rat Parietal Bones. J Bone Miner Res. 1994 Feb;9(2):193-201./[3]Pierre-Henri Puech, et al. Measuring Cell Adhesion Forces of Primary Gastrulating Cells From Zebrafish Using Atomic Force Microscopy. J Cell Sci. 2005 Sep 15;118(Pt 18):4199-206.

CAS Number: 111119-28-9

Molecular Weight: 715.76

Compound Purity: 99.70

Research Area: Metabolic Disease; Cardiovascular Disease

Solubility: H2O

Target: Integrin

• Artikelnummer: MEXHY-P0322-25
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P0322-25
• Green Labware: Nein
• Verpackungseinheit: 25 mg
• Mengeneinheit: STK